Drug-eluting balloons for restenosis after stent implantation

Affiliations

¹ Interventional Cardiology, Cardiovascular Institute, Clínico San Carlos University Hospital, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid 28040, Spain. falf@hotmail.com

Comment

Fernando Alfonso et al. Lancet. 2013.

. 2013 Feb 9;381(9865):431-3.

doi: 10.1016/S0140-6736(12)62120-5. Epub 2012 Dec 1.

¹ Interventional Cardiology, Cardiovascular Institute, Clínico San Carlos University Hospital, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid 28040, Spain. falf@hotmail.com

No abstract available

Comment on

Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial.
Byrne RA, Neumann FJ, Mehilli J, Pinieck S, Wolff B, Tiroch K, Schulz S, Fusaro M, Ott I, Ibrahim T, Hausleiter J, Valina C, Pache J, Laugwitz KL, Massberg S, Kastrati A; ISAR-DESIRE 3 investigators. Byrne RA, et al. Lancet. 2013 Feb 9;381(9865):461-7. doi: 10.1016/S0140-6736(12)61964-3. Epub 2012 Dec 1. Lancet. 2013. PMID: 23206837 Clinical Trial.